Ryo Sawada

Late-onset Pleural and Pericardial Effusion as Immune-related Adverse Events after 94 Cycles of Nivolumab

K. Takayama, J. Uchino, Tadaaki Yamada, 2021, Internal medicine.

Predictive value of p53 and AXL immunostaining for the efficacy of immune checkpoint inhibitor-based therapy after osimertinib treatment in patients with epidermal growth factor-mutant non-small cell lung cancer

Young Hak Kim, K. Takayama, K. Azuma, 2023, Cancer Immunology, Immunotherapy.

A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With EGFR-Mutant NSCLC

K. Takayama, K. Azuma, Tadaaki Yamada, 2022, JTO clinical and research reports.

AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells.

K. Kunimasa, Shinsaku Tokuda, K. Morimoto, 2024, Cancer letters.

A Case of Bronchobiliary Fistula Successfully Treated for Bronchial Occlusion Using Endobronchial Watanabe Spigot and Embolization Coils

Ryo Sawada, Chie Yamamoto, Naoya Nishioka, 2023, Respiratory Endoscopy.